-+ 0.00%
-+ 0.00%
-+ 0.00%

Eli Lilly: According to US Securities and Exchange Commission documents, asset impairment, restructuring, and other special expenses confirmed in the three months ending September 30 was US$303 million.

Zhitongcaijing·10/29/2026 15:49:11
Listen to the news
Eli Lilly: According to US Securities and Exchange Commission documents, asset impairment, restructuring, and other special expenses confirmed in the three months ending September 30 was US$303 million.